Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of the anti-HIV drugs
efavirenz and lamivudine/zidovudine given to treatment-naive HIV-infected people in Dakar,
Senegal.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Initiative Senegalaise d'Acces aux Antiretroviraux (ISAARV)
Treatments:
Efavirenz Lamivudine Lamivudine, zidovudine drug combination Zidovudine